Genetic testing company 23andMe, once celebrated for its promise to revolutionize genetics and healthcare, has filed for Chapter 11 bankruptcy protection, with co-founder and CEO Anne Wojcicki resigning in an effort to preserve the company’s future prospects. The news follows failed attempts to take 23andMe private, highlighting the challenges the company has faced in establishing a sustainable business model. Despite the turmoil, Wojcicki remains optimistic, insisting her “belief in the company and its future is unwavering.” The fate of its groundbreaking genetic testing kits, health research endeavors, and millions of customers remains uncertain. (AP)
